pre-seed
Stage
1
Investors
About
Nantkwest develops next-generation natural killer (NK) cell-based immunotherapies for the treatment of cancer and infectious diseases.
Explore Nantkwest's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.